Specific Human Milk Oligosaccharides Differentially Promote Th1 and Regulatory Responses in a CpG-Activated Epithelial/Immune Cell Coculture
Biomolecules · 2023
DOI: 10.3390/biom13020263 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, 2023. Verfasst von Marit Zuurveld und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University, 3584 CG Utrecht, The Netherlands. Hauptthemen laut MEDLINE: Milk, Human, Leukocytes, Mononuclear. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Health Holland, TKI Health Holland.
Abstract (Originalsprache)
Proper early life immune development creates a basis for a healthy and resilient immune system, which balances immune tolerance and activation. Deviations in neonatal immune maturation can have life-long effects, such as development of allergic diseases. Evidence suggests that human milk oligosaccharides (HMOS) possess immunomodulatory properties essential for neonatal immune maturation. To understand the immunomodulatory properties of enzymatic or bacterial produced HMOS, the effects of five HMOS (2′FL, 3FL, 3′SL, 6′SL and LNnT), present in human milk have been studied. A PBMC immune model, the IEC barrier model and IEC/PBMC transwell coculture models were used, representing critical steps in mucosal immune development. HMOS were applied to IEC cocultured with activated PBMC. In the presence of CpG, 2′FL and 3FL enhanced IFNγ (p < 0.01), IL10 (p < 0.0001) and galectin-9 (p < 0.001) secretion when added to IEC; 2′FL and 3FL decreased Th2 cell development while 3FL enhanced Treg polarization (p < 0.05). IEC were required for this 3FL mediated Treg polarization, which was not explained by epithelial-derived galectin-9, TGFβ nor retinoic acid secretion. The most pronounced immunomodulatory effects, linking to enhanced type 1 and regulatory mediator secretion, were observed for 2′FL and 3FL. Future studies are needed to further understand the complex interplay between HMO and early life mucosal immune development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University, 3584 CG Utrecht, The Netherlands.
- Danone Nutricia Research B.V., 3584 CT Utrecht, The Netherlands.
- Center for Translational Immunology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.
ORCID-Profile: Marit Zuurveld, Veronica Ayechu-Muruzabal, Gert Folkerts, Johan Garssen, Linette E M Willemsen
Förderung
- Health Holland
- TKI Health Holland
Zitieren
APA
Zuurveld, M., Ayechu-Muruzabal, V., Folkerts, G., Garssen, J., Van't Land, B., & Willemsen, L. E. M. (2023). Specific Human Milk Oligosaccharides Differentially Promote Th1 and Regulatory Responses in a CpG-Activated Epithelial/Immune Cell Coculture. Biomolecules. https://doi.org/10.3390/biom13020263
Vancouver
Zuurveld M, Ayechu-Muruzabal V, Folkerts G, Garssen J, Van't Land B, Willemsen LEM. Specific Human Milk Oligosaccharides Differentially Promote Th1 and Regulatory Responses in a CpG-Activated Epithelial/Immune Cell Coculture. Biomolecules. 2023. doi:10.3390/biom13020263
BibTeX
@article{Zuurveld2023,
author = {Zuurveld, Marit and Ayechu-Muruzabal, Veronica and Folkerts, Gert and Garssen, Johan and Van't Land, Belinda and Willemsen, Linette E M},
title = {Specific Human Milk Oligosaccharides Differentially Promote Th1 and Regulatory Responses in a CpG-Activated Epithelial/Immune Cell Coculture},
journal = {Biomolecules},
year = {2023},
doi = {10.3390/biom13020263}
}
EUVIMED